Breaking News Instant updates and real-time market news.

FRC

First Republic

$172.57 /

+7.815 (+4.74%)

08:53
03/02/21
03/02
08:53
03/02/21
08:53

First Republic 1.75M share Spot Secondary priced at $166.50

The deal size was increased to 1.75M shares from 1.5M and priced at low end of $166.50-$169.95 range. BofA, JPMorgan and Morgan Stanley are acting as joint book running managers for the offering.

  • 12

    Nov

  • 02

    Mar

FRC First Republic
$172.57 /

+7.815 (+4.74%)

01/15/21 Maxim
First Republic price target raised to $200 from $195 at Maxim
01/15/21 Citi
First Republic price target raised to $163 from $141 at Citi
01/04/21 Barclays
First Republic price target raised to $156 from $130 at Barclays
12/31/20 Compass Point
Compass Point raises price target on 'top pick' First Republic to $165

TODAY'S FREE FLY STORIES

Earnings
First Hawaiian reports Q1 EPS 44c, consensus 44c » 08:16
04/23/21
04/23
08:16
04/23/21
08:16
FHB

First Hawaiian

$27.05 /

-0.09 (-0.33%)

Total assets were $23.5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHB First Hawaiian
$27.05 /

-0.09 (-0.33%)

FHB First Hawaiian
$27.05 /

-0.09 (-0.33%)

11/19/20 JPMorgan
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan
07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
FHB First Hawaiian
$27.05 /

-0.09 (-0.33%)

Hot Stocks
Inovio sinks after Department of Defense stops vaccine trial funding » 08:15
04/23/21
04/23
08:15
04/23/21
08:15
INO

Inovio

$9.13 /

-0.02 (-0.22%)

Shares of Inovio are…

Shares of Inovio are sinking after the Department of Defense decided to stop funding the company's Covid-19 vaccine trial in the U.S. The Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense told Inovio that it will discontinue funding for the Phase 3 segment of the INNOVATE trial, while continuing to fund the completion of the ongoing Phase 2 segment. In correspondence, JPEO informed Inovio: "The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines. This decision is not a reflection of the awardee or product, rather a fast-moving environment associated with the former Operation Warp Speed on decisions related to future products." The decision does not impact other work that Inovio does with the U.S. government and is neither a result of the partial clinical hold nor a reflection of the data generated to date for INO-4800 vaccine, the company said in a statement. The company is planning for a predominantly outside the U.S. Phase 3 trial based on upcoming evaluation of Phase 2 safety and immunogenicity data. Inovio shares in premarket trading are down 23%, or $2.13, to $7.00.

ShowHide Related Items >><<
INO Inovio
$9.13 /

-0.02 (-0.22%)

INO Inovio
$9.13 /

-0.02 (-0.22%)

03/23/21
Fly Intel: Top five analyst initiations
03/23/21 BofA
Inovio initiated with a Neutral at BofA
03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
INO Inovio
$9.13 /

-0.02 (-0.22%)

  • 21
    Jan
INO Inovio
$9.13 /

-0.02 (-0.22%)

INO Inovio
$9.13 /

-0.02 (-0.22%)

Hot Stocks
Yunji announces appointment of Wei Ye as executive president » 08:15
04/23/21
04/23
08:15
04/23/21
08:15
YJ

Yunji

$2.00 /

-0.035 (-1.72%)

Yunji announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YJ Yunji
$2.00 /

-0.035 (-1.72%)

YJ Yunji
$2.00 /

-0.035 (-1.72%)

11/30/20 Morgan Stanley
Yunji downgraded to Underweight from Equal Weight at Morgan Stanley
YJ Yunji
$2.00 /

-0.035 (-1.72%)

Earnings
Gentex sees 2022 revenue 8%-13% higher than 2021 revenue, consensus $2.18B » 08:14
04/23/21
04/23
08:14
04/23/21
08:14
GNTX

Gentex

$35.62 /

-0.51 (-1.41%)

Based on the mid-April…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

GNTX Gentex
$35.62 /

-0.51 (-1.41%)

02/01/21 B. Riley Securities
Gentex price target raised to $40 from $38.75 at B. Riley Securities
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Seaport Global
Seaport starts Gentex with Neutral, awaits better entry point
01/28/21 Seaport Global
Gentex initiated with a Neutral at Seaport Global
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

Upgrade
Clearfield upgraded to Outperform from Market Perform at Northland » 08:13
04/23/21
04/23
08:13
04/23/21
08:13
CLFD

Clearfield

$29.93 /

+0.16 (+0.54%)

Northland analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLFD Clearfield
$29.93 /

+0.16 (+0.54%)

01/29/21 Lake Street
Clearfield price target raised to $37 from $25 at Lake Street
01/29/21 Northland
Clearfield downgraded to Market Perform from Outperform at Northland
12/08/20 Northland
Clearfield price target raised to $26 from $24 at Northland
12/08/20 Northland
Calix price target raised to $30 from $28 at Northland
Earnings
Gentex sees 2021 revenue $1.94B-$2.02B, consensus $2B » 08:12
04/23/21
04/23
08:12
04/23/21
08:12
GNTX

Gentex

$35.62 /

-0.51 (-1.41%)

The Company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

GNTX Gentex
$35.62 /

-0.51 (-1.41%)

02/01/21 B. Riley Securities
Gentex price target raised to $40 from $38.75 at B. Riley Securities
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Seaport Global
Seaport starts Gentex with Neutral, awaits better entry point
01/28/21 Seaport Global
Gentex initiated with a Neutral at Seaport Global
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

Upgrade
Imax upgraded to Outperform from Neutral at Wedbush » 08:12
04/23/21
04/23
08:12
04/23/21
08:12
IMAX

Imax

$21.32 /

+0.18 (+0.85%)

Wedbush analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAX Imax
$21.32 /

+0.18 (+0.85%)

IMAX Imax
$21.32 /

+0.18 (+0.85%)

04/05/21 B. Riley Securities
B. Riley upgrades AMC to Buy with $13 target after 'impressive' weekend
03/24/21 B. Riley Securities
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
03/09/21 Barrington
Imax price target raised to $27 from $25 at Barrington
03/05/21 Macquarie
Imax price target raised to $25 after Q4 earnings beat at Macquarie
IMAX Imax
$21.32 /

+0.18 (+0.85%)

IMAX Imax
$21.32 /

+0.18 (+0.85%)

IMAX Imax
$21.32 /

+0.18 (+0.85%)

IMAX Imax
$21.32 /

+0.18 (+0.85%)

Hot Stocks
MicroVision jumps another 7% in pre-market on WallStreetBets focus » 08:12
04/23/21
04/23
08:12
04/23/21
08:12
MVIS

MicroVision

$13.13 /

+0.61 (+4.87%)

Shares of Microvision are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MVIS MicroVision
$13.13 /

+0.61 (+4.87%)

MVIS MicroVision
$13.13 /

+0.61 (+4.87%)

05/06/20 Craig-Hallum
MicroVision rise driven by Microsoft speculation, says Craig-Hallum
MVIS MicroVision
$13.13 /

+0.61 (+4.87%)

MVIS MicroVision
$13.13 /

+0.61 (+4.87%)

MVIS MicroVision
$13.13 /

+0.61 (+4.87%)

Hot Stocks
DLH Holdings wins $202M contract to provide medical logistics to the VA » 08:12
04/23/21
04/23
08:12
04/23/21
08:12
DLHC

DLH Holdings

$10.38 /

+0.08 (+0.78%)

DLH Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLHC DLH Holdings
$10.38 /

+0.08 (+0.78%)

DLHC DLH Holdings
$10.38 /

+0.08 (+0.78%)

DLHC DLH Holdings
$10.38 /

+0.08 (+0.78%)

Hot Stocks
Purple Biotech announces dosing of first patient in Phase 1b/2 trial of CM24 » 08:11
04/23/21
04/23
08:11
04/23/21
08:11
PPBT

Purple Biotech

$4.45 /

-0.2 (-4.30%)

Purple Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPBT Purple Biotech
$4.45 /

-0.2 (-4.30%)

PPBT Purple Biotech
$4.45 /

-0.2 (-4.30%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
PPBT Purple Biotech
$4.45 /

-0.2 (-4.30%)

Earnings
Gentex reports Q1 EPS 46c, consensus 49c » 08:11
04/23/21
04/23
08:11
04/23/21
08:11
GNTX

Gentex

$35.62 /

-0.51 (-1.41%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

GNTX Gentex
$35.62 /

-0.51 (-1.41%)

02/01/21 B. Riley Securities
Gentex price target raised to $40 from $38.75 at B. Riley Securities
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Seaport Global
Seaport starts Gentex with Neutral, awaits better entry point
01/28/21 Seaport Global
Gentex initiated with a Neutral at Seaport Global
GNTX Gentex
$35.62 /

-0.51 (-1.41%)

Initiation
NIO initiated with a Buy at CLSA » 08:09
04/23/21
04/23
08:09
04/23/21
08:09
NIO

NIO

$39.60 /

+0.7 (+1.80%)

CLSA analyst Soobin Park…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$39.60 /

+0.7 (+1.80%)

NIO NIO
$39.60 /

+0.7 (+1.80%)

04/20/21 Mizuho
Tesla price target raised to $820 from $775 at Mizuho
03/11/21
Fly Intel: Top five analyst initiations
03/10/21 Mizuho
Mizuho starts 'leader and innovator' NIO with Buy rating, $60 target
03/10/21 Mizuho
NIO initiated with a Buy at Mizuho
NIO NIO
$39.60 /

+0.7 (+1.80%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$39.60 /

+0.7 (+1.80%)

NIO NIO
$39.60 /

+0.7 (+1.80%)

NIO NIO
$39.60 /

+0.7 (+1.80%)

Hot Stocks
Coherus says Toripalimab achieved primary endpoints in Phase 3 trial » 08:09
04/23/21
04/23
08:09
04/23/21
08:09
CHRS

Coherus Biosciences

$14.62 /

-0.13 (-0.88%)

Coherus BioSciences has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHRS Coherus Biosciences
$14.62 /

-0.13 (-0.88%)

CHRS Coherus Biosciences
$14.62 /

-0.13 (-0.88%)

02/25/21 Citi
Coherus Biosciences price target lowered to $27 from $30 at Citi
02/25/21 H.C. Wainwright
Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright
11/19/20 Mizuho
Coherus Biosciences price target lowered to $30 from $35 at Mizuho
08/21/20 Mizuho
Express Scripts exclusion does not impact Coherus, says Mizuho
CHRS Coherus Biosciences
$14.62 /

-0.13 (-0.88%)

Hot Stocks
Athleta announces long-term partnership with Simone Biles » 08:09
04/23/21
04/23
08:09
04/23/21
08:09
GPS

Gap

$33.24 /

+0.43 (+1.31%)

Athleta, a Gap brand,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$33.24 /

+0.43 (+1.31%)

GPS Gap
$33.24 /

+0.43 (+1.31%)

04/19/21 JPMorgan
Gap price target raised to $37 from $32 at JPMorgan
04/13/21 Morgan Stanley
Synchrony loss of Gap card deal 'likely a positive,' says Morgan Stanley
03/15/21 Wells Fargo
Gap price target raised to $40 from $32 at Wells Fargo
03/09/21 MKM Partners
Gap price target raised to $29 from $21 at MKM Partners
GPS Gap
$33.24 /

+0.43 (+1.31%)

GPS Gap
$33.24 /

+0.43 (+1.31%)

GPS Gap
$33.24 /

+0.43 (+1.31%)

GPS Gap
$33.24 /

+0.43 (+1.31%)

Earnings
Coty backs FY21 revenue view $4.5B-$4.6B, consensus $4.57B » 08:08
04/23/21
04/23
08:08
04/23/21
08:08
COTY

Coty

$9.20 /

+0.11 (+1.21%)

Backs FY21 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COTY Coty
$9.20 /

+0.11 (+1.21%)

COTY Coty
$9.20 /

+0.11 (+1.21%)

04/16/21 DA Davidson
Coty price target raised to $9.25 from $6 at DA Davidson
02/10/21
Fly Intel: Top five analyst upgrades
02/10/21 Evercore ISI
Evercore raises Coty to Outperform, says turnaround 'a question of when,' not if
02/10/21 Evercore ISI
Coty upgraded to Outperform from In Line at Evercore ISI
COTY Coty
$9.20 /

+0.11 (+1.21%)

COTY Coty
$9.20 /

+0.11 (+1.21%)

COTY Coty
$9.20 /

+0.11 (+1.21%)

COTY Coty
$9.20 /

+0.11 (+1.21%)

Recommendations
HCA Healthcare price target raised to $230 from $200 at Oppenheimer » 08:06
04/23/21
04/23
08:06
04/23/21
08:06
HCA

HCA Healthcare

$201.52 /

+3.96 (+2.00%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

07:16 Today Barclays
HCA Healthcare price target raised to $225 from $195 at Barclays
07:00 Today Deutsche Bank
HCA Healthcare price target raised to $225 from $210 at Deutsche Bank
06:50 Today Mizuho
HCA Healthcare price target raised to $232 from $205 at Mizuho
06:45 Today RBC Capital
HCA Healthcare price target raised to $232 from $205 at RBC Capital
HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

HCA HCA Healthcare
$201.52 /

+3.96 (+2.00%)

Hot Stocks
Energy Fuels awarded additional $1.75M for feasibility study for DOE » 08:05
04/23/21
04/23
08:05
04/23/21
08:05
UUUU

Energy Fuels

$5.27 /

-0.26 (-4.70%)

Energy Fuels announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UUUU Energy Fuels
$5.27 /

-0.26 (-4.70%)

UUUU Energy Fuels
$5.27 /

-0.26 (-4.70%)

03/23/21 H.C. Wainwright
Energy Fuels price target raised to $7.25 from $4.50 at H.C. Wainwright
01/13/21 Cantor Fitzgerald
Energy Fuels upgraded to Buy from Hold at Cantor Fitzgerald
01/06/21 Cantor Fitzgerald
Energy Fuels downgraded to Hold from Buy at Cantor Fitzgerald
12/14/20 Cantor Fitzgerald
Cameco downgraded to Hold from Buy at Cantor Fitzgerald
UUUU Energy Fuels
$5.27 /

-0.26 (-4.70%)

Hot Stocks
Inovio planning for ex-U.S. global Phase 3 trial for INO-4800 » 08:05
04/23/21
04/23
08:05
04/23/21
08:05
INO

Inovio

$9.13 /

-0.02 (-0.22%)

Inovio announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INO Inovio
$9.13 /

-0.02 (-0.22%)

INO Inovio
$9.13 /

-0.02 (-0.22%)

03/23/21
Fly Intel: Top five analyst initiations
03/23/21 BofA
Inovio initiated with a Neutral at BofA
03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
INO Inovio
$9.13 /

-0.02 (-0.22%)

  • 21
    Jan
INO Inovio
$9.13 /

-0.02 (-0.22%)

INO Inovio
$9.13 /

-0.02 (-0.22%)

Hot Stocks
OneSpan CFO Mark Hoyt to leave company » 08:03
04/23/21
04/23
08:03
04/23/21
08:03
OSPN

OneSpan

$27.98 /

+0.32 (+1.16%)

OneSpan announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSPN OneSpan
$27.98 /

+0.32 (+1.16%)

OSPN OneSpan
$27.98 /

+0.32 (+1.16%)

04/15/21 Sidoti
OneSpan upgraded to Buy from Neutral at Sidoti
03/31/21 DA Davidson
OneSpan initiated with a Buy at DA Davidson as revenue growth accelerates
03/30/21 DA Davidson
OneSpan initiated with a Buy at DA Davidson
02/19/21 Sidoti
OneSpan downgraded to Neutral from Buy at Sidoti
OSPN OneSpan
$27.98 /

+0.32 (+1.16%)

OSPN OneSpan
$27.98 /

+0.32 (+1.16%)

Upgrade
Travelzoo upgraded to Outperform from Market Perform at Noble Capital » 08:02
04/23/21
04/23
08:02
04/23/21
08:02
TZOO

Travelzoo

$14.62 /

-0.38 (-2.53%)

Noble Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TZOO Travelzoo
$14.62 /

-0.38 (-2.53%)

TZOO Travelzoo
$14.62 /

-0.38 (-2.53%)

03/25/21 Ascendiant
Travelzoo upgraded to Buy from Hold at Ascendiant
03/18/21 Noble Capital
Travelzoo downgraded to Market Perform from Outperform at Noble Capital
09/14/20 Noble Capital
Travelzoo initiated with an Outperform at Noble Capital
09/02/20 Barrington
Travelzoo price target raised to $11 from $7.50 at Barrington
TZOO Travelzoo
$14.62 /

-0.38 (-2.53%)

Initiation
Clearway Energy initiated with a Buy at Tudor Pickering » 08:02
04/23/21
04/23
08:02
04/23/21
08:02
CWEN

Clearway Energy

$28.70 /

+0.22 (+0.77%)

Tudor Pickering initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CWEN Clearway Energy
$28.70 /

+0.22 (+0.77%)

CWEN Clearway Energy
$28.70 /

+0.22 (+0.77%)

03/30/21 Seaport Global
Clearway Energy upgraded to Buy from Neutral at Seaport Global
03/25/21 Wolfe Research
Clearway Energy upgraded to Outperform from Peer Perform at Wolfe Research
12/15/20 Seaport Global
Clearway Energy downgraded to Neutral after re-rating at Seaport Global
12/15/20 Seaport Global
Clearway Energy downgraded to Neutral from Buy at Seaport Global
CWEN Clearway Energy
$28.70 /

+0.22 (+0.77%)

CWEN Clearway Energy
$28.70 /

+0.22 (+0.77%)

Hot Stocks
AbbVie receives positive CHMP opinion for VENCLYXTO combination therapy » 08:01
04/23/21
04/23
08:01
04/23/21
08:01
ABBV

AbbVie

$110.05 /

-0.73 (-0.66%)

AbbVie announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

ABBV AbbVie
$110.05 /

-0.73 (-0.66%)

Hot Stocks
WiMi Hologram Cloud receives patent for holographic imaging system » 08:01
04/23/21
04/23
08:01
04/23/21
08:01
WIMI

WiMi Hologram Cloud

$5.76 /

+0.095 (+1.68%)

WiMi Hologram Cloud…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WIMI WiMi Hologram Cloud
$5.76 /

+0.095 (+1.68%)

WIMI WiMi Hologram Cloud
$5.76 /

+0.095 (+1.68%)

12/30/20
Fly Intel: Top five analyst calls
12/30/20 Benchmark
Benchmark starts WiMi Hologram Cloud at Buy with $8 price target
12/30/20 Benchmark
WiMi Hologram Cloud initiated with a Buy at Benchmark
07/13/20 Maxim
WiMi Hologram downgraded to Hold from Buy at Maxim
WIMI WiMi Hologram Cloud
$5.76 /

+0.095 (+1.68%)

WIMI WiMi Hologram Cloud
$5.76 /

+0.095 (+1.68%)

Options
Advanced Micro put buyer realizes 15% same-day gains » 08:00
04/23/21
04/23
08:00
04/23/21
08:00
AMD

AMD

$79.06 /

-2.53 (-3.10%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$79.06 /

-2.53 (-3.10%)

AMD AMD
$79.06 /

-2.53 (-3.10%)

04/22/21 Citi
Intel shares are at near-term peak, says Citi
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Raymond James
AMD initiated with an Outperform at Raymond James
04/15/21 Raymond James
AMD initiated with an Outperform at Raymond James
AMD AMD
$79.06 /

-2.53 (-3.10%)

AMD AMD
$79.06 /

-2.53 (-3.10%)

AMD AMD
$79.06 /

-2.53 (-3.10%)

AMD AMD
$79.06 /

-2.53 (-3.10%)

Upgrade
TAL Education upgraded to Outperform from Neutral at Credit Suisse » 07:58
04/23/21
04/23
07:58
04/23/21
07:58
TAL

TAL Education

$61.63 /

-1.42 (-2.25%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

07:57 Today Nomura
Nomura downgrades TAL Education to Neutral on lack of catalysts
07:51 Today Nomura
TAL Education downgraded to Neutral from Buy at Nomura
07:18 Today Benchmark
TAL Education price target lowered to $78 from $95 at Benchmark
06:48 Today Morgan Stanley
TAL Education price target lowered to $75 from $84 at Morgan Stanley
TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

TAL TAL Education
$61.63 /

-1.42 (-2.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.